Temasek, Sequoia Capital back $90m round in China's JW Therapeutics

Retrieved on: 2018-03-08 08:56:15

Tags for this article:

Finance

Business

Click the tags to see associated articles and topics

Temasek, Sequoia Capital back $90m round in China's JW Therapeutics. View article details on hiswai:

Excerpt

<div>A consortium of leading global investors including Temasek and <b>Sequoia Capital</b> China has joined the $90-million Series A financing round of Shanghai-based biotech startup JW Therapeutics, according to an official announcement. Others investors who joined the round include YuanMing Capital, ...</div>

Article found on:

View Original Article